News – Page 368 – Endpoints News

Galapagos sends some employees — and a research unit — off to drug discovery CRO as part of reorg

3 years ago

Senate Finance Committee lobs more bipartisan pressure onto PBMs

3 years ago

MPP recruits three generic manufacturers to expand use of ViiV's injectable PrEP drug

3 years ago

Real patient ‘champions’ living with HIV star in Theratechnologies campaign

3 years ago

Acquisition talks ongoing for Swedish rare disease biotech Egetis, shares up almost 40%

3 years ago

Lupus drug development market heating up, while FDA links with advocacy group to further accelerate research

3 years ago

Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm

3 years ago

After safety review, EMA mirrors FDA with updated recommendations for JAK inhibitors

3 years ago

Manufacturing roundup: Catalent to produce low-cost version of naloxone; CSL opens R&D site

3 years ago

Aspen looks to rebound in production and revenue after Covid-19

3 years ago

Moderna solidifies deal with Kenya to build mRNA manufacturing facility

3 years ago

Thermo Fisher moves on campus with new cell manufacturing site in San Francisco

3 years ago

Nanoscope’s eye disease gene therapy shows mixed results in PhII

3 years ago

FDA grants full approval to Keytruda in tumor-agnostic setting; Candel pauses trial enrollment

3 years ago

FDA lifts partial clinical hold on Vigil Neuroscience's TREM2 antibody, removing dosing cap

3 years ago

Daiichi Sankyo inks $183M discovery deal with GPCR biotech for CNS target

3 years ago

Diffusion to hand Nasdaq spot to EIP Pharma for PhIIb dementia study of ex-Vertex drug

3 years ago

GSK picks up Scynexis' FDA-approved antifungal drug for $90M upfront

3 years ago

Seelos Therapeutics 'temporarily' stops study in rare neuro disorder for business reasons

3 years ago

Alector cuts 11% of workforce as it doubles down on late-stage neuro programs partnered with GSK, AbbVie

3 years ago

Hearing-focused biotech grabs trio of programs from Otonomy's fire sale

3 years ago

Mathai Mammen hands in J&J's R&D keys to lead Greg Verdine’s FogPharma

3 years ago

Q&A: Newly-minted CSL chief executive Paul McKenzie and chief medical officer Bill Mezzanotte

3 years ago

UK government, private investors dole out $340M+ to drug, diagnostic manufacturers

3 years ago

First page Previous page 365 366 367368369 370 371 Next page Last page